This review forms part of a series of annual updates that summarize the evidence base for atopic eczema (AE), providing a succinct guide for clinicians and patients. It provides a summary of key findings from 15 systematic reviews that were published during 2015, and focuses on the epidemiology and methodology issues of AE. For systematic reviews on the prevention and treatment of AE, see Part 2 of this update. The worldwide prevalence of AE during childhood has been calculated to be 7.89% (95% CI 7.88-7.89), based on studies of 1 430 329 children from 102 countries. Children with AE are four times more likely than controls to have allergic rhinitis and asthma [relative risk (RR) = 4.24, 95% CI 3.75-4.79]. Twin studies show the heritability of AE to be about 75%. AE is more prevalent in patients with vitiligo and alopecia, and is positively associated with a high body mass index in America and Asia but not in Europe. Possible relationships between AE and exercise, maternal folate supplementation, maternal stress and autism spectrum disorder (ASD) have been assessed, but more high-quality studies are needed for definitive conclusions. The Harmonising Outcomes Measures for Eczema (HOME) Initiative is developing a core set of outcome measures for AE trials. Suitable instruments for measuring quality of life are yet to be agreed, and use of Investigator Global Assessment in trials requires standardization. Transparent reporting of AE trials remains problematic.
Background
Atopic eczema (AE) is one of the most prevalent diseases worldwide 1 and its study is a fast moving field. The aim of this two-part evidence update is to present key findings from systematic reviews published in 2015, summarizing the findings of systematic reviews (SRs) on the methodological issues and epidemiology of AE. For an update of SRs on the prevention and treatment of AE, see Part 2 of this update.
This overview continues our series of AE updates published on an annual basis in Clinical and Experimental Dermatology.
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Epidemiology of atopic eczema and atopy
The relationship between AE, asthma and rhinitis in children was examined by Pols et al. 5 in their review of 31 cross-sectional or cohort studies, encompassing 1 430 329 children aged 0-18 years from 102 countries. The worldwide prevalence of AE was 7.89% (95% CI 7.88-7.89). For children with AE, the calculated risk ratio of having both asthma and allergic rhinitis was 4.24, 95% CI 3.75-4.79. A group of children had all three conditions (prevalence 1.17%; 95% CI 1.17-1.18).
Heritability of atopic eczema
Elmose et al 6 evaluated eight twin studies published since 1970, and estimated the overall heritability of AE to be approximately 75% (n = 155 twin pairs), and the association between AE and asthma to be approximately 85% (n = 21 203 twin pairs).
Association between food sensitization and atopic eczema
Alduraywish and colleagues 7 addressed AE and early food sensitization (defined as positive IgE or skin prick test) by evaluating birth cohort studies published since 1950. Food sensitization in the first 2 years of life was associated with childhood AE (OR = 2.71, 95% CI 1.67-4.39) in five of the eight studies. Most studies involved children with risk factors for developing AE. Studies of a longer duration that include participants with and without AE in infancy are needed to establish whether or not the presence of food sensitization in infancy increases the risk of developing AE in adulthood.
The role of chemokines
The association of CCL5 (À403 G/A, À28C/G) gene polymorphisms with AE susceptibility was assessed by Wen et al.
8 Meta-analysis of three studies (one casecontrol, two cohort) including German, Hungarian and Japanese populations found no difference between cases and controls. (OR = 0.38, 95% CI 1.08-1.76 and OR = 1.06, 95% CI 0.65-1.72 respectively).
Maternal stress and atopic eczema
Anderson et al. 9 evaluated maternal stress and risk of atopy. The six studies pertinent to AE defined maternal stress in a variety of ways, and were too heterogeneous to allow meta-analysis. Future studies in this area should aim to develop a standardized definition of what constitutes maternal stress and use validated AE diagnostic criteria.
Physical activity
Seven cross-sectional studies investigating associations between physical activity and AE for a total of 61 974 adults and children were reviewed by Kim et al. 10 No association between AE and physical activity was shown in a meta-analysis of four extremely heterogeneous studies that evaluated activity performed once a week or more (OR = 1.04, 95% CI 0.92-1.17), nor was an association found when evaluating exercise performed three times a week or more in two more homogenous studies (OR = 1.11, 95% CI 0.88-1.4). The authors concluded that the variation in definitions of physical activity and where the activity was performed, and a lack of control for confounding factors, made it difficult to draw firm conclusions.
Gut bacteria
Melli et al., 11 building on work by Penders et al., 12 reviewed 21 studies assessing intestinal microbiota in atopic children. There was some suggestion that atopic children have less diverse gut bacteria than nonatopic children, but the authors did not separately assess AE, nor did all of the included studies explicitly identify AE as a form of atopy.
Maternal folate supplementation
The review of maternal folate supplementation and allergic disease by Wang et al. 13 assessed four casecontrol or cohort AE studies. Meta-analysis of two of these studies showed no association [relative risk (RR) = 1.15, 95% CI 0.91-1.45]. However, as two excluded studies indicated an inverse relationship, more work is needed to clarify the role of maternal folate supplementation in terms of AE risk.
Obesity
The association between body mass index (BMI) and AE was examined in 30 heterogeneous, mostly crosssectional, studies of variable quality. 13 High BMI was associated with a small increased risk of AE in North American (OR = 1.53, 95% CI 1.24-1.89) and Asian populations (OR = 1.3, 95% CI 1.14-1.48), but not European populations (OR 1.01, 95% CI 0.8-1.28).
Association of atopic eczema with other conditions
Mohan et al.
14 assessed the association between AE and vitiligo (16 studies, 10 200 patients from 11 countries) and alopecia areata (17 studies, 798 597 patients from 11 countries). Pooled data from two studies showed a positive association between vitiligo and AE (OR = 7.82, 95% CI 3.06-20.00). Pooled data from three studies showed higher odds of AE if the vitiligo developed before 12 years of age compared with development at an older age (OR = 3.54, 95% CI ª 2018 British Association of Dermatologists 2.24-5.63). Data pooled from three studies also showed a positive association between alopecia areata and AE (OR = 2.57, 95% CI, 2.25-2.94). Metaanalysis of four studies showed those with alopecia universalis or totalis had higher odds of AE compared with those with patchy alopecia areata (OR = 1.22, 95% CI 1.01-1.48).
Lymphoma risk in patients with AE was assessed in 23 studies covering 1 302 068 patients. 15 Although meta-analysis of 4 cohort studies demonstrated an increased risk of lymphoma in patients with AE (RR = 1.43, 95% CI 1.12-1.81), 18 highly heterogeneous case-control studies found no association (OR = 1.18, 95% CI 0.94-1.47). Two case-control and one cohort study showed an association between cutaneous lymphoma and AE severity (severity defined by medical resource usage). Although an association between high-potency corticosteroid use and lymphoma was shown in two studies (OR = 1.73, 95% CI 1.52-1.97), lymphoma can be misdiagnosed as severe AE, and more potent corticosteroids (noted to be associated with lymphoma) are more likely to be used for severe AE. No association with tacrolimus or pimecrolimus use and lymphoma was observed.
Bellici et al. 16 assessed the association between AE and autism spectrum disorder using data collected from 18 surveys and studies (case-control, longitudinal) comprising 1 245 225 participants. Although there was no overall agreement, probably due to heterogeneity in AE assessment/definition, the majority indicated a positive association, and one study found a stronger association with more severe AE. 17 
Methodological issues in eczema studies
A recurring theme in systematic reviews is that heterogeneous studies (both in study design and reporting) are difficult to compare.
As part of the Harmonising Outcome Measures for Eczema (HOME) initiative, Heinl et al. 18 summarized validation studies for 17 adult quality of life instruments. The review identified considerable validation gaps for all of the included instruments. The Quality of Life Index for Atopic Dermatitis (QoLIAD) and Dermatology Life Quality Index (DLQI) were the most promising scales for further validation, but existing studies suggest that the DLQI has poor internal consistency, content and structural validity.
Futamura et al. 19 looked at methods to capture global assessment of disease severity in 317 randomized controlled trials (RCTs) of eczema treatments published between 2000 and 2014. A third of the studies used Investigator Global Assessment as an outcome, but there was little consistency in how this was measured, making comparison between studies difficult.
Finally, a review on the quality of reporting AE trials by Ratib et al. 20 found that 12% of AE RCTs published between 2004 and 2013 incorrectly reported withingroup rather than between-group differences, as would be appropriate for a comparison of two interventions, leading to misrepresentation of the importance of the trial findings. The authors supported mandatory dermatology trial registration entailing declaration of study outcomes prior to start of recruitment.
Conclusions
Recent systematic reviews support associations between AE and other atopic diseases, as well as with autoimmune diseases such as vitiligo and alopecia areata. Better-quality studies are required to elucidate associations between AE and exercise, maternal folate supplementation, maternal stress and autism spectrum disorder. Efforts have been made to improve reporting of AE trials, but limitations in reporting and outcome measure heterogeneity persist.
Learning points
• Children with AE are four times more likely to have asthma and allergic rhinitis compared with the general population.
• The heritability of AE is approximately 75%.
• Birth cohort studies show that food sensitization is associated with AE in childhood, but it is not possible to comment on causality, and evidence on food sensitization and AE in adulthood is lacking due to the absence of long-term follow-up.
• In America and Asia, but not Europe, AE is associated with increased BMI.
• Patients with alopecia areata and vitiligo are more likely to have AE than controls, and there may be an association between autism spectrum disorder and AE.
• More work is needed to ascertain whether maternal folate supplementation is beneficial in terms of AE risk in the infant.
• Poor research design remains a problem in eczema research, and validated quality of life scales are lacking.
CPD questions Learning objective
To demonstrate up-to-date knowledge of epidemiology and methodology in atopic eczema.
Question 1
If a child has atopic eczema (AE), how likely are they to have asthma and allergic rhinitis compared to the general population? 
Question 2
Regarding food sensitization and atopic eczema (AE), which of the following statements is true? 
